NEURL3

Across TCGA pan-cancer cohorts, NEURL3 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NEURL3 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NEURL3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NEURL3 expression acts as an unfavorable survival marker.

UCEC, LUSC, and SKCM are the cancer types where NEURL3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUSC	DFS	Median	All	0.225	0.661	.030	3	view →
SKCM	OS	Median	IV	0.415	0.861	.014	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

NEURL3–UCEC (OS)

Open the UCEC breakdown →